These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 37193913)

  • 1. Alogliptin: a DPP-4 inhibitor modulating adipose tissue insulin resistance and atherogenic lipid.
    Kutoh E; Kuto AN; Akiyama M; Ozawa E; Kurihara R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):947-959. PubMed ID: 37193913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study.
    Singh H; Rohilla R; Jaswal S; Singla M
    Expert Rev Endocrinol Metab; 2024; 19(1):81-87. PubMed ID: 38078453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse Strategies for Modulating Insulin Resistance: Causal or Consequential Inference on Metabolic Parameters in Treatment-Naïve Subjects with Type 2 Diabetes.
    Kutoh E; Kuto AN; Okada R; Akiyama M; Kurihara R
    Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929608
    [No Abstract]   [Full Text] [Related]  

  • 4. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control.
    Della Pepa G; Carli F; Sabatini S; Pezzica S; Russo M; Vitale M; Masulli M; Riccardi G; Rivellese AA; Vaccaro O; Bozzetto L; Gastaldelli A
    Diabetes Metab Res Rev; 2024 May; 40(4):e3798. PubMed ID: 38558269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teneligliptin as an initial therapy for newly diagnosed, drug naive subjects with type 2 diabetes.
    Kutoh E; Hirate M; Ikeno Y
    J Clin Med Res; 2014 Aug; 6(4):287-94. PubMed ID: 24883155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.
    Mita T; Katakami N; Yoshii H; Onuma T; Kaneto H; Osonoi T; Shiraiwa T; Yasuda T; Umayahara Y; Yamamoto T; Yokoyama H; Kuribayashi N; Jinnouchi H; Gosho M; Shimomura I; Watada H
    Sci Rep; 2023 Sep; 13(1):14649. PubMed ID: 37669959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Growth Hormone Predicts Worsening Adipose Tissue Insulin Resistance in Adults with Obesity.
    Li X; Zhou B; Yao Y; Wang G; Meng H
    Obes Facts; 2023; 16(4):401-410. PubMed ID: 37231915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in the adipose tissue predicts future vascular resistance: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases.
    Sasaki N; Ueno Y; Ozono R; Nakano Y; Higashi Y
    Atherosclerosis; 2024 Jun; 393():117547. PubMed ID: 38703418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedentary Time Is Independently Related to Adipose Tissue Insulin Resistance in Adults With or at Risk of Type 2 Diabetes.
    Engin B; Willis SA; Malaikah S; Sargeant JA; Biddle GJH; Razieh C; Argyridou S; Edwardson CL; Jelleyman C; Stensel DJ; Henson J; Rowlands AV; Davies MJ; Yates T; King JA
    Med Sci Sports Exerc; 2023 Sep; 55(9):1548-1554. PubMed ID: 37093903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Action of Natural Dipeptidyl Peptidase-IV Inhibitors (Berberine and Mangiferin) in Experimentally Induced Diabetes with Metabolic Syndrome.
    Suman RK; Borde MK; Mohanty IR; Singh HK
    Int J Appl Basic Med Res; 2023; 13(3):133-142. PubMed ID: 38023603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids.
    Mourad AAE; Khodir AE; Saber S; Mourad MAE
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33670273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Regular Exercise and its Duration on Metabolic Parameters.
    Goktas O; Ersoy C
    J Coll Physicians Surg Pak; 2023 Nov; 33(11):1330-1332. PubMed ID: 37926891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus.
    Lyu YS; Oh S; Kim JH; Kim SY; Jeong MH
    Cardiovasc Diabetol; 2023 Jul; 22(1):185. PubMed ID: 37481509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin levels in maternal serum at birth and eczema risk in offspring in early childhood: A birth cohort study.
    Ziyab AH; Jones AD; Chen S; Anthony TM; Mukherjee N; Arshad SH; Karmaus W
    Pediatr Allergy Immunol; 2023 Jun; 34(6):e13979. PubMed ID: 37366203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis.
    Huang YL; Xu XZ; Liu J; Wang PY; Wang XL; Feng HL; Liu CJ; Han X
    BMC Cardiovasc Disord; 2023 Jun; 23(1):293. PubMed ID: 37296380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers.
    Orsini D; Gargiulo L; Ibba L; Cascio Ingurgio R; Valenti M; Perugini C; Pacifico A; Maramao FS; Frascione P; Costanzo A; Narcisi A
    J Dermatolog Treat; 2023 Dec; 34(1):2220849. PubMed ID: 37288760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.
    Fu EL; Patorno E; Everett BM; Vaduganathan M; Solomon SD; Levin R; Schneeweiss S; Desai RJ
    Eur Heart J; 2023 Jun; 44(24):2216-2230. PubMed ID: 37259575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk.
    Scilletta S; Di Marco M; Miano N; Filippello A; Di Mauro S; Scamporrino A; Musmeci M; Coppolino G; Di Giacomo Barbagallo F; Bosco G; Scicali R; Piro S; Purrello F; Di Pino A
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238622
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.